Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
S M GrunbergM Krailo

Abstract

Metoclopramide is an effective antiemetic for cisplatin-induced vomiting when given in parenteral high-dose regimens but not oral low-dose regimens. Metoclopramide was compared to haloperidol, also given in a high-dose parenteral regimen. Patients received two cycles of cisplatin at a dose greater than or equal to 70 mg/m2. Metoclopramide (2 mg/kg intravenous) was given every two hours for five doses beginning one half hour before cisplatin. Haloperidol (3 mg intravenous) was given on the same schedule. A randomized double-blind crossover design was used to control subjective bias and to compare the same patient's experiences. Twenty-eight patients completed both study arms. Excellent control of vomiting was achieved with both drugs. Metoclopramide resulted in 1.92 vomiting episodes (range, 0-5) with 36% having no vomiting. Haloperidol resulted in 3.04 vomiting episodes (range, 0-8) with 20% having no vomiting. Significantly fewer vomiting episodes were noted with metoclopramide rho = .006, paired sign test). However, responses to the two drugs were well correlated (Spearman's rho = .39, P = .03). Metoclopramide and haloperidol are both excellent antiemetics when given in sufficient dosage by an effective route. Metoclopramide ...Continue Reading

Citations

Oct 18, 1991·Pharmaceutisch Weekblad. Scientific Edition·C SeynaeveR J Gralla
Apr 15, 1988·Cancer·K S Sridhar, E Donnelly
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J GrallaD G Pfister
Oct 1, 1993·Postgraduate Medicine·Syed Bilgrami, Barbara G Fallon
Jan 1, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J HerrstedtM Hansen
Sep 10, 2014·Expert Opinion on Drug Safety·Louise BryggerUNKNOWN Academy of Geriatric Cancer Research (AgeCare)
Jan 1, 1987·Cancer Investigation·S M Grunberg
Jul 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·R A Clark, R J Gralla
Sep 8, 2010·Journal of Feline Medicine and Surgery·Saeed Kolahian, Seyedhosein Jarolmasjed
Jan 1, 1984·Cancer Investigation·J J Fiore, R J Gralla
Dec 9, 1993·The New England Journal of Medicine·S M Grunberg, P J Hesketh
Aug 13, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jørn HerrstedtAlexander Molassiotis
Nov 3, 2015·The Cochrane Database of Systematic Reviews·Fay Murray-Brown, Saskie Dorman
Oct 1, 1986·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·W J Richtsmeier, E M Mazur
Oct 14, 1985·The Medical Journal of Australia·J H Kearsley, M H Tattersall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here